Dopamine pathway gene variants may modulate cognitive performance in the DHS - Mind Study.
BACKGROUND
There is an established association between type 2 diabetes and accelerated cognitive decline. The exact mechanism linking type 2 diabetes and reduced cognitive function is less clear. The monoamine system, which is extensively involved in cognition, can be altered by type 2 diabetes status. Thus, this study hypothesized that sequence variants in genes linked to dopamine metabolism and associated pathways are associated with cognitive function as assessed by the Digit Symbol Substitution Task, the Modified Mini-Mental State Examination, the Stroop Task, the Rey Auditory-Verbal Learning Task, and the Controlled Oral Word Association Task for Phonemic and Semantic Fluency in the Diabetes Heart Study, a type 2 diabetes-enriched familial cohort (n = 893).


METHODS
To determine the effects of candidate variants on cognitive performance, genetic association analyses were performed on the well-documented variable number tandem repeat located in the 3' untranslated region of the dopamine transporter, as well as on single-nucleotide polymorphisms covering genes in the dopaminergic pathway, the insulin signaling pathway, and the convergence of both. Next, polymorphisms in loci of interest with strong evidence for involvement in dopamine processing were extracted from genetic datasets available in a subset of the cohort (n = 572) derived from Affymetrix(®) Genome-Wide Human SNP Array 5.0 and 1000 Genomes imputation from this array.


RESULTS
The candidate gene analysis revealed one variant from the DOPA decarboxylase gene, rs10499695, to be associated with poorer performance on a subset of Rey Auditory-Verbal Learning Task measuring retroactive interference (P = 0.001, β = -0.45). Secondary analysis of genome-wide and imputed data uncovered another DOPA decarboxylase variant, rs62445903, also associated with retroactive interference (P = 7.21 × 10(-7), β = 0.3). These data suggest a role for dopaminergic genes, specifically a gene involved in regulation of dopamine synthesis, in cognitive performance in type 2 diabetes.
['Martelle|Susan E|SE|', 'Raffield|Laura M|LM|', 'Palmer|Nichole D|ND|', 'Cox|Amanda J|AJ|', 'Freedman|Barry I|BI|', 'Hugenschmidt|Christina E|CE|', 'Williamson|Jeff D|JD|', 'Bowden|Don W|DW|']
D000328:Adult D000368:Aged D000369:Aged, 80 and over D001142:Aromatic-L-Amino-Acid Decarboxylases D060825:Cognitive Dysfunction D015331:Cohort Studies D003924:Diabetes Mellitus, Type 2 D004298:Dopamine D050483:Dopamine Plasma Membrane Transport Proteins D005260:Female D055106:Genome-Wide Association Study D006801:Humans D008297:Male D008875:Middle Aged D018598:Minisatellite Repeats D010375:Pedigree D020641:Polymorphism, Single Nucleotide D015398:Signal Transduction
dopamine Cognition type 2 diabetes polymorphism DOPA decarboxylase DAT1 VNTR